midazolam has been researched along with Migraine with Aura in 1 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Migraine with Aura: A subtype of migraine disorder, characterized by recurrent attacks of reversible neurological symptoms (aura) that precede or accompany the headache. Aura may include a combination of sensory disturbances, such as blurred VISION; HALLUCINATIONS; VERTIGO; NUMBNESS; and difficulty in concentrating and speaking. Aura is usually followed by features of the COMMON MIGRAINE, such as PHOTOPHOBIA; PHONOPHOBIA; and NAUSEA. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afridi, SK | 1 |
| Giffin, NJ | 1 |
| Kaube, H | 1 |
| Goadsby, PJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Ketamine for Refractory Chronic Migraine: a Pilot Study[NCT03896256] | Early Phase 1 | 6 participants (Actual) | Interventional | 2019-03-22 | Completed | ||
| Intranasal Ketamine Versus Intranasal Midazolam Plus Fentanyl in Treating Pain Associated With Incision and Drainage of Abscesses in the Pediatric Emergency Department: A Randomized Controlled Trial[NCT02635282] | Phase 4 | 19 participants (Actual) | Interventional | 2016-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for midazolam and Migraine with Aura
| Article | Year |
|---|---|
A randomized controlled trial of intranasal ketamine in migraine with prolonged aura.
Topics: Administration, Intranasal; Adult; Analgesics; Double-Blind Method; Female; Humans; Inpatients; Keta | 2013 |
A randomized controlled trial of intranasal ketamine in migraine with prolonged aura.
Topics: Administration, Intranasal; Adult; Analgesics; Double-Blind Method; Female; Humans; Inpatients; Keta | 2013 |
A randomized controlled trial of intranasal ketamine in migraine with prolonged aura.
Topics: Administration, Intranasal; Adult; Analgesics; Double-Blind Method; Female; Humans; Inpatients; Keta | 2013 |
A randomized controlled trial of intranasal ketamine in migraine with prolonged aura.
Topics: Administration, Intranasal; Adult; Analgesics; Double-Blind Method; Female; Humans; Inpatients; Keta | 2013 |